Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Genes and Immunity|March 15, 2008
Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individualsR D Levinson, Z Du, L Luo, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohortA Vienne, T Simon, J Cosnes, et al.
La Revue De Medecine Interne|May 5, 2023
French recommendations for the management of non-infectious chronic uveitisP Quartier, D Saadoun, A Belot, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 5, 2023
Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care centerN Hammoudi, J Lehmann-Che, J Lambert, et al.
Arthritis and Rheumatism|December 14, 2004
Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patientsS Abad, V Meyssonier, J Allali, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Pageof 12